PDF] Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients
CAV Regimen
Small Cell Lung Cancer Palak Desai, MD. - ppt download
PDF] Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients
Current Oncology | Free Full-Text | Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer
A Randomized Study Comparing Cyclophosphamide, Doxorubicin, Vincristine (CAV) with Cyclophosphamide, Etoposide, Vincristine, Met
Cav-1 induces the survival of GC cell lines in the presence of... | Download Scientific Diagram
Current Oncology | Free Full-Text | Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer
BIO treatment regulate the translational activity of Cav-1 promoter A... | Download Scientific Diagram
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions - Megyesfalvi - 2023 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: Randomized trial, can it improve surviv
ASCO 2023: MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab Versus Avelumab After First-Line Platinum-Based Chemotherapy in Patients with Metastatic Urothelial Cancer
Table 4 from Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma
Cav-1 induces the survival of GC cell lines in the presence of... | Download Scientific Diagram
Alternating Chemotherapy with Cyclophosphamide/Adriamycin/Vincristine (CAV) and Cisplatin/Etoposide (PVP) against Small Cell Lun
Pilot study of cyclophosphamideâ•'doxorubicinâ•'vincristineâ•'cisplatinâ•'etoposide hybrid chemotherapy in s